Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

The Effect of Lactobacillus gasseri BNR17 on Postmenopausal Symptoms in Ovariectomized Rats

  • 2021-09-28
  • Journal of Microbiology and Biotechnology 31(9)
    • Sol Lee
    • D. Jung
    • Miri Park
    • S. Yeon
    • Sang-Hyuk Jung
    • S. Yun
    • Han-Oh Park
    • Wonbeak Yoo

Study Design

Type
Clinical Trial
Population
Ovariectomized rats
Methods
In vivo experiment with an animal model.
  • Animal Study

Abstract

Clinical and preclinical studies have reported that Lactobacillus gasseri BNR17, a probiotic bacterial strain isolated from human breast milk, reduces body weight and white adipose tissue volume. In order to further explore the actions of L. gasseri BNR17, we investigated the anti-menopausal effects of L. gasseri BNR17 in an ovariectomized (OVX) rat model. The serum alanine aminotransferase levels of the rats in the OVX-BNR17 group were lower than those of the rats in the OVX-vehicle only (OVX-Veh) group. Upon administration of L. gasseri BNR17 after ovariectomy, calcitonin and Serotonin 2A levels increased significantly, whereas serum osteocalcin levels showed a decreasing tendency. Compared to the rats in the OVX-Veh group, those in the OVX-BNR17 group showed lower urine deoxypyridinoline levels, lower pain sensitivity, and improved vaginal cornification. Furthermore, L. gasseri BNR17 administration increased bone mineral density in the rats with OVX-induced femoral bone loss. These results suggest that L. gasseri BNR17 administration could alleviate menopausal symptoms, indicating that this bacterium could be a good functional probiotic for managing the health of older women.

Keywords: Lactobacillus gasseri BNR17; menopause symptoms; ovariectomized rats.

Research Insights

Back to top